Breaking News Instant updates and real-time market news.

NUVSF

Nuvista Energy

$0.00 /

+ (+0.00%)

14:03
02/26/21
02/26
14:03
02/26/21
14:03

Nuvista Energy price target raised to C$2.50 from C$1.25 at BMO Capital

BMO Capital analyst Ray Kwan raised the firm's price target on Nuvista Energy to C$2.50 from C$1.25 and keeps a Market Perform rating on the shares.

NUVSF Nuvista Energy
$0.00 /

+ (+0.00%)

02/26/21 CIBC
Nuvista Energy price target raised to C$2.25 from C$1.25 at CIBC
02/26/21 National Bank
Nuvista Energy upgraded to Outperform from Sector Perform at National Bank
02/26/21 Scotiabank
Nuvista Energy price target raised to C$2.20 from C$1.50 at Scotiabank
02/26/21 TD Securities
Nuvista Energy price target raised to C$2 from C$1 at TD Securities

TODAY'S FREE FLY STORIES

Options
Square call volume above normal and directionally bullish » 11:05
04/12/21
04/12
11:05
04/12/21
11:05
SQ

Square

$259.68 /

-2.08 (-0.79%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
$259.68 /

-2.08 (-0.79%)

SQ Square
$259.68 /

-2.08 (-0.79%)

04/09/21 Credit Suisse
Square price target raised to $290 from $270 at Credit Suisse
04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Oddo BHF
Square initiated with a Neutral at Oddo BHF
04/07/21 Barclays
Barclays boosts Square target to $330 on potential for international upside
SQ Square
$259.68 /

-2.08 (-0.79%)

SQ Square
$259.68 /

-2.08 (-0.79%)

SQ Square
$259.68 /

-2.08 (-0.79%)

SQ Square
$259.68 /

-2.08 (-0.79%)

General news
European Fixed Income Summary: » 11:05
04/12/21
04/12
11:05
04/12/21
11:05
$ECON

Economic Data

/

+

European Fixed Income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler » 11:02
    04/12/21
    04/12
    11:02
    04/12/21
    11:02
    ITOS

    iTeos Therapeutics

    $25.41 /

    -1.495 (-5.56%)

    Piper Sandler analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ITOS iTeos Therapeutics
    $25.41 /

    -1.495 (-5.56%)

    ITOS iTeos Therapeutics
    $25.41 /

    -1.495 (-5.56%)

    04/09/21 Piper Sandler
    AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
    04/05/21 Piper Sandler
    Piper Sandler continues to recommend iTeos Therapeutics into data
    03/25/21 Wedbush
    iTeos Therapeutics price target raised to $52 from $46 at Wedbush
    10/07/20 Baird
    iTeos Therapeutics initiated with an Outperform at Baird
    ITOS iTeos Therapeutics
    $25.41 /

    -1.495 (-5.56%)

    • 24
      Jul
    Recommendations
    Provention Bio price target lowered to $22.50 from $35 at Chardan » 11:02
    04/12/21
    04/12
    11:02
    04/12/21
    11:02
    PRVB

    Provention Bio

    $8.00 /

    +0.01 (+0.13%)

    Chardan analyst Gbola…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PRVB Provention Bio
    $8.00 /

    +0.01 (+0.13%)

    PRVB Provention Bio
    $8.00 /

    +0.01 (+0.13%)

    04/09/21 SVB Leerink
    Provention Bio price target lowered to $16 from $26 at SVB Leerink
    04/09/21 RBC Capital
    Provention Bio cut to Sector Perform at RBC Capital after teplizumab FDA notice
    04/09/21 Cantor Fitzgerald
    Provention Bio price target lowered to $25 from $27 at Cantor Fitzgerald
    04/09/21 RBC Capital
    Provention Bio downgraded to Sector Perform from Outperform at RBC Capital
    PRVB Provention Bio
    $8.00 /

    +0.01 (+0.13%)

    • 14
      Jan
    • 18
      Jun
    PRVB Provention Bio
    $8.00 /

    +0.01 (+0.13%)

    Recommendations
    Sage Therapeutics essential tremor data 'a win,' says Piper Sandler » 10:58
    04/12/21
    04/12
    10:58
    04/12/21
    10:58
    SAGE

    Sage Therapeutics

    $74.43 /

    -2.3 (-3.00%)

    Piper Sandler analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SAGE Sage Therapeutics
    $74.43 /

    -2.3 (-3.00%)

    SAGE Sage Therapeutics
    $74.43 /

    -2.3 (-3.00%)

    04/07/21 Piper Sandler
    Sage Therapeutics assumed with an Overweight at Piper Sandler
    02/26/21 Mizuho
    Sage Therapeutics downgraded to Neutral from Buy at Mizuho
    02/25/21 Oppenheimer
    Sage Therapeutics price target raised to $102 from $90 at Oppenheimer
    02/25/21 H.C. Wainwright
    Sage Therapeutics price target raised to $86 from $74 at H.C. Wainwright
    SAGE Sage Therapeutics
    $74.43 /

    -2.3 (-3.00%)

    SAGE Sage Therapeutics
    $74.43 /

    -2.3 (-3.00%)

    Options
    Nautilus put volume heavy and directionally bearish » 10:55
    04/12/21
    04/12
    10:55
    04/12/21
    10:55
    NLS

    Nautilus

    $16.12 /

    -0.455 (-2.75%)

    Bearish flow noted in…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    03/19/21 Craig-Hallum
    Nautilus price target lowered to $25 from $30 at Craig-Hallum
    03/19/21 Roth Capital
    Nautilus price target lowered to $26 from $29 at Roth Capital
    03/19/21 William Blair
    Nautilus 2026 margin target sent shares down 10%, says William Blair
    03/19/21 Craig-Hallum
    Nautilus price target lowered to $25 from $30 at Craig-Hallum
    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    Conference/Events
    Microsoft to host conference call » 10:55
    04/12/21
    04/12
    10:55
    04/12/21
    10:55
    NUAN

    Nuance

    $53.30 /

    +7.705 (+16.90%)

    , MSFT

    Microsoft

    $255.41 /

    -0.32 (-0.13%)

    Conference call to…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    NUAN Nuance
    $53.30 /

    +7.705 (+16.90%)

    MSFT Microsoft
    $255.41 /

    -0.32 (-0.13%)

    NUAN Nuance
    $53.30 /

    +7.705 (+16.90%)

    08:30 Today Stifel
    Microsoft a 'logical buyer' of Nuance, says Stifel
    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    03/10/21 Wedbush
    Nuance added to Best Ideas List at Wedbush
    MSFT Microsoft
    $255.41 /

    -0.32 (-0.13%)

    08:30 Today Stifel
    Microsoft a 'logical buyer' of Nuance, says Stifel
    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    07:11 Today BMO Capital
    Microsoft price target raised to $280 from $270 at BMO Capital
    NUAN Nuance
    $53.30 /

    +7.705 (+16.90%)

    MSFT Microsoft
    $255.41 /

    -0.32 (-0.13%)

    NUAN Nuance
    $53.30 /

    +7.705 (+16.90%)

    MSFT Microsoft
    $255.41 /

    -0.32 (-0.13%)

    NUAN Nuance
    $53.30 /

    +7.705 (+16.90%)

    MSFT Microsoft
    $255.41 /

    -0.32 (-0.13%)

    NUAN Nuance
    $53.30 /

    +7.705 (+16.90%)

    MSFT Microsoft
    $255.41 /

    -0.32 (-0.13%)

    Syndicate
    Recursion Pharmaceuticals 18M share IPO price range $16.00-$18.00 » 10:49
    04/12/21
    04/12
    10:49
    04/12/21
    10:49
    RXRX

    Recursion Pharmaceuticals

    /

    +

    Goldman Sachs and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    Earnings
    SBA sees at least $22.5M more straight-line revenue in 2021 than prior guidance » 10:47
    04/12/21
    04/12
    10:47
    04/12/21
    10:47
    SBAC

    SBA Communications

    $277.53 /

    +2.03 (+0.74%)

    , VZ

    Verizon

    $57.60 /

    +0.14 (+0.24%)

    In a regulatory filing,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    SBAC SBA Communications
    $277.53 /

    +2.03 (+0.74%)

    VZ Verizon
    $57.60 /

    +0.14 (+0.24%)

    SBAC SBA Communications
    $277.53 /

    +2.03 (+0.74%)

    08:01 Today Jefferies
    SBA Communications initiated with a Buy at Jefferies
    03/25/21 KeyBanc
    SBA Communications upgraded to Overweight from Sector Weight at KeyBanc
    03/18/21 Wolfe Research
    SBA Communications initiated with an Outperform at Wolfe Research
    03/05/21 Raymond James
    SBA Communications upgraded to Strong Buy from Outperform at Raymond James
    VZ Verizon
    $57.60 /

    +0.14 (+0.24%)

    03/30/21 KeyBanc
    KeyBanc sees partnership with Google as neutral to T-Mobile
    03/24/21 Tigress Financial
    Verizon upgraded to Buy at Tigress Financial
    03/24/21 Tigress Financial
    Verizon upgraded to Buy from Neutral at Tigress Financial
    03/12/21 Morgan Stanley
    T-Mobile highlighted 'impressive' cash flow ramp at event, says Morgan Stanley
    SBAC SBA Communications
    $277.53 /

    +2.03 (+0.74%)

    VZ Verizon
    $57.60 /

    +0.14 (+0.24%)

    SBAC SBA Communications
    $277.53 /

    +2.03 (+0.74%)

    VZ Verizon
    $57.60 /

    +0.14 (+0.24%)

    VZ Verizon
    $57.60 /

    +0.14 (+0.24%)

    VZ Verizon
    $57.60 /

    +0.14 (+0.24%)

    Syndicate
    Biomea Fusion 7.5M share IPO price range $15.00-$17.00 » 10:46
    04/12/21
    04/12
    10:46
    04/12/21
    10:46
    BMEA

    Biomea Fusion

    /

    +

    JPMorgan, Jefferies and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    Options
    180 Life Sciences call volume above normal and directionally bullish » 10:45
    04/12/21
    04/12
    10:45
    04/12/21
    10:45
    ATNF

    180 Life Sciences

    $12.19 /

    +2.49 (+25.67%)

    Bullish option flow…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    ATNF 180 Life Sciences
    $12.19 /

    +2.49 (+25.67%)

    ATNF 180 Life Sciences
    $12.19 /

    +2.49 (+25.67%)

    ATNF 180 Life Sciences
    $12.19 /

    +2.49 (+25.67%)

    Syndicate
    Akoya Biosciences 6.58M share IPO price range $18.00-$20.00 » 10:44
    04/12/21
    04/12
    10:44
    04/12/21
    10:44
    AKYA

    Akoya Biosciences

    /

    +

    JPMorgan, Morgan Stanley,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    Hot Stocks
    PLBY Group shares jump as Hedgeye adds as a new best idea » 10:40
    04/12/21
    04/12
    10:40
    04/12/21
    10:40
    PLBY

    PLBY Group

    $28.75 /

    +2.97 (+11.52%)

    PLBY Group (PLBY) has…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PLBY PLBY Group
    $28.75 /

    +2.97 (+11.52%)

    PLBY PLBY Group
    $28.75 /

    +2.97 (+11.52%)

    04/07/21 Roth Capital
    PLBY Group price target raised to $35 from $26 at Roth Capital
    04/06/21 Canaccord
    Canaccord sees Nifty Gateway partnership as initial step in PLBY's NFT strategy
    03/31/21 Canaccord
    PLBY Group initiated with a Buy at Canaccord
    03/24/21 Craig-Hallum
    PLBY Group price target raised to $35 from $25 at Craig-Hallum
    PLBY PLBY Group
    $28.75 /

    +2.97 (+11.52%)

    PLBY PLBY Group
    $28.75 /

    +2.97 (+11.52%)

    Periodicals
    Denmark's DSB orders e-trains from Alstom in $3.2B deal, Reuters reports » 10:39
    04/12/21
    04/12
    10:39
    04/12/21
    10:39
    ALSMY

    Alstom

    $5.29 /

    +0.06 (+1.15%)

    DSB, the state-owned…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ALSMY Alstom
    $5.29 /

    +0.06 (+1.15%)

    ALSMY Alstom
    $5.29 /

    +0.06 (+1.15%)

    03/17/21 JPMorgan
    Alstom price target lowered to EUR 51 from EUR 52 at JPMorgan
    03/15/21 Citi
    Citi opens 'negative catalyst watch' on Alstom
    03/03/21 Morgan Stanley
    Alstom price target raised to EUR 59 from EUR 55 at Morgan Stanley
    02/23/21 UBS
    Alstom price target lowered to EUR 50 from EUR 54 at UBS
    Conference/Events
    Limbach Holding participates in a conference call hosted by Lake Street » 10:35
    04/12/21
    04/12
    10:35
    04/12/21
    10:35
    LMB

    Limbach Holding

    $10.88 /

    -0.42 (-3.72%)

    Lake Street holds a…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    LMB Limbach Holding
    $10.88 /

    -0.42 (-3.72%)

    LMB Limbach Holding
    $10.88 /

    -0.42 (-3.72%)

    03/05/21
    Fly Intel: Top five analyst initiations
    03/05/21 Lake Street
    Limbach Holding initiated with a Buy at Lake Street
    LMB Limbach Holding
    $10.88 /

    -0.42 (-3.72%)

    • 11
      Feb
    Options
    KE Holdings put volume heavy and directionally bearish » 10:35
    04/12/21
    04/12
    10:35
    04/12/21
    10:35
    BEKE

    KE Holdings

    $54.01 /

    -1.84 (-3.29%)

    Bearish flow noted in KE…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BEKE KE Holdings
    $54.01 /

    -1.84 (-3.29%)

    BEKE KE Holdings
    $54.01 /

    -1.84 (-3.29%)

    04/07/21 Credit Suisse
    KE Holdings initiated with an Outperform at Credit Suisse
    03/18/21 BofA
    KE Holdings upgraded to Buy from Neutral at BofA
    03/18/21 BofA
    KE Holdings upgraded to Buy from Neutral at BofA
    03/11/21 Goldman Sachs
    KE Holdings upgraded to Buy from Neutral at Goldman Sachs
    BEKE KE Holdings
    $54.01 /

    -1.84 (-3.29%)

    • 19
      Nov
    • 13
      Aug
    BEKE KE Holdings
    $54.01 /

    -1.84 (-3.29%)

    Conference/Events
    Boxlight participates in a conference call hosted by Maxim » 10:32
    04/12/21
    04/12
    10:32
    04/12/21
    10:32
    BOXL

    Boxlight

    $2.36 /

    -0.11 (-4.45%)

    Maxim hosts conference…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    BOXL Boxlight
    $2.36 /

    -0.11 (-4.45%)

    BOXL Boxlight
    $2.36 /

    -0.11 (-4.45%)

    03/26/21 Alliance Global Partners
    Boxlight price target raised to $5.50 from $5 at Alliance Global Partners
    01/26/21 Alliance Global Partners
    Boxlight price target raised to $5 from $4 at Alliance Global Partners
    10/05/20 Maxim
    Boxlight price target raised to $6 from $4 at Maxim
    10/01/20 Alliance Global Partners
    Boxlight price target raised to $4 from $2.75 at Alliance Global Partners
    BOXL Boxlight
    $2.36 /

    -0.11 (-4.45%)

    • 29
      Jul
    • 09
      Jun
    BOXL Boxlight
    $2.36 /

    -0.11 (-4.45%)

    Conference/Events
    Sellas Life Sciences participates in a conference call hosted by Maxim » 10:31
    04/12/21
    04/12
    10:31
    04/12/21
    10:31
    SLS

    Sellas Life Sciences

    $8.45 /

    -0.59 (-6.53%)

    Maxim hosts conference…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SLS Sellas Life Sciences
    $8.45 /

    -0.59 (-6.53%)

    SLS Sellas Life Sciences
    $8.45 /

    -0.59 (-6.53%)

    02/09/21 Maxim
    Heat data puts cancer vaccine discussion 'back on the table,' says Maxim
    12/21/20 Alliance Global Partners
    Alliance Global Partners keeps Buy on Sellas following data from trials
    SLS Sellas Life Sciences
    $8.45 /

    -0.59 (-6.53%)

    SLS Sellas Life Sciences
    $8.45 /

    -0.59 (-6.53%)

    SLS Sellas Life Sciences
    $8.45 /

    -0.59 (-6.53%)

    Options
    Micron call volume above normal and directionally bullish » 10:25
    04/12/21
    04/12
    10:25
    04/12/21
    10:25
    MU

    Micron

    $95.93 /

    +0.58 (+0.61%)

    Bullish option flow…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MU Micron
    $95.93 /

    +0.58 (+0.61%)

    MU Micron
    $95.93 /

    +0.58 (+0.61%)

    04/01/21 Wedbush
    Micron price target raised to $105 from $100 at Wedbush
    04/01/21 JPMorgan
    Micron price target raised to $140 from $130 at JPMorgan
    04/01/21 Needham
    Micron price target raised to $130 from $115 at Needham
    04/01/21 Cowen
    Micron price target raised to $105 from $100 at Cowen
    MU Micron
    $95.93 /

    +0.58 (+0.61%)

    MU Micron
    $95.93 /

    +0.58 (+0.61%)

    MU Micron
    $95.93 /

    +0.58 (+0.61%)

    MU Micron
    $95.93 /

    +0.58 (+0.61%)

    Conference/Events
    Rackspace Technology to hold a virtual roundtable » 10:25
    04/12/21
    04/12
    10:25
    04/12/21
    10:25
    FORR

    Forrester

    $41.61 /

    -0.2 (-0.48%)

    , DELL

    Dell Technologies

    $93.09 /

    -0.79 (-0.84%)

    , RXT

    Rackspace Technology

    $25.65 /

    -0.42 (-1.61%)

    Virtual Roundtable…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    DELL Dell Technologies
    $93.09 /

    -0.79 (-0.84%)

    RXT Rackspace Technology
    $25.65 /

    -0.42 (-1.61%)

    FORR Forrester
    $41.61 /

    -0.2 (-0.48%)

    02/16/21 Barrington
    Forrester price target raised to $50 from $44 at Barrington
    08/03/20 Barrington
    Forrester price target raised to $44 from $40 at Barrington
    DELL Dell Technologies
    $93.09 /

    -0.79 (-0.84%)

    04/08/21 Morgan Stanley
    Dell Technologies price target raised to $107 from $98 at Morgan Stanley
    04/07/21 Deutsche Bank
    Dell Technologies price target raised to $100 from $94 at Deutsche Bank
    02/26/21 JPMorgan
    Dell Technologies price target raised to $98 from $90 at JPMorgan
    02/26/21 Credit Suisse
    Dell Technologies price target raised to $80 from $70 at Credit Suisse
    RXT Rackspace Technology
    $25.65 /

    -0.42 (-1.61%)

    04/01/21 William Blair
    William Blair starts Rackspace with Outperform, sees 30% upside
    03/31/21 William Blair
    Rackspace Technology initiated with an Outperform at William Blair
    01/25/21 Oppenheimer
    Rackspace Technology initiated with an Outperform at Oppenheimer
    09/01/20 BMO Capital
    Rackspace Technology price target raised to $25 from $23 at BMO Capital
    FORR Forrester
    $41.61 /

    -0.2 (-0.48%)

    DELL Dell Technologies
    $93.09 /

    -0.79 (-0.84%)

    RXT Rackspace Technology
    $25.65 /

    -0.42 (-1.61%)

    • 05
      Aug
    DELL Dell Technologies
    $93.09 /

    -0.79 (-0.84%)

    RXT Rackspace Technology
    $25.65 /

    -0.42 (-1.61%)

    DELL Dell Technologies
    $93.09 /

    -0.79 (-0.84%)

    RXT Rackspace Technology
    $25.65 /

    -0.42 (-1.61%)

    DELL Dell Technologies
    $93.09 /

    -0.79 (-0.84%)

    RXT Rackspace Technology
    $25.65 /

    -0.42 (-1.61%)

    Conference/Events
    Cardiff Oncology to hold a Key Opinion Leader conference call » 10:25
    04/12/21
    04/12
    10:25
    04/12/21
    10:25
    CRDF

    Cardiff Oncology

    $9.43 /

    +0.18 (+1.95%)

    CEO Erlander, along with…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    CRDF Cardiff Oncology
    $9.43 /

    +0.18 (+1.95%)

    CRDF Cardiff Oncology
    $9.43 /

    +0.18 (+1.95%)

    02/11/21 Piper Sandler
    Piper says Cardiff Oncology mCRPC opportunity 'more interesting' after data
    10/22/20
    Fly Intel: Top five analyst initiations
    10/22/20 H.C. Wainwright
    Cardiff Oncology initiated with a Buy at H.C. Wainwright
    10/21/20 Maxim
    Cardiff Oncology price target raised to $20 from $14 at Maxim
    CRDF Cardiff Oncology
    $9.43 /

    +0.18 (+1.95%)

    • 30
      Sep
    CRDF Cardiff Oncology
    $9.43 /

    +0.18 (+1.95%)

    Conference/Events
    UBS electric equip/multi-industry analysts hold analyst/industry conference call » 10:25
    04/12/21
    04/12
    10:25
    04/12/21
    10:25

    Electrical Equipment…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Hot Stocks
    Nam Tai says ISS, Glass Lewis both say change in board control not warranted » 10:23
    04/12/21
    04/12
    10:23
    04/12/21
    10:23
    NTP

    Nam Tai Property

    $11.90 /

    +0.22 (+1.88%)

    Nam Tai Property issued…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    NTP Nam Tai Property
    $11.90 /

    +0.22 (+1.88%)

    On The Fly
    Alibaba jumps as China fine seen removing overhang » 10:20
    04/12/21
    04/12
    10:20
    04/12/21
    10:20
    BABA

    Alibaba

    $242.26 /

    +18.91 (+8.47%)

    Shares of Alibaba Group…

    ShowHide Related Items >><<
    BABA Alibaba
    $242.26 /

    +18.91 (+8.47%)

    BABA Alibaba
    $242.26 /

    +18.91 (+8.47%)

    08:37 Today Morgan Stanley
    Alibaba named a Research Tactical Idea at Morgan Stanley
    07:37 Today Raymond James
    Alibaba price target lowered to $330 from $350 at Raymond James
    06:41 Today Mizuho
    Alibaba antitrust ruling 'removes overhang,' says Mizuho
    06:37 Today Citi
    Alibaba fine could help lift 'overhang' on shares, says Citi
    BABA Alibaba
    $242.26 /

    +18.91 (+8.47%)

    BABA Alibaba
    $242.26 /

    +18.91 (+8.47%)

    BABA Alibaba
    $242.26 /

    +18.91 (+8.47%)

    BABA Alibaba
    $242.26 /

    +18.91 (+8.47%)

    Hot Stocks
    Akari announces initiation of pivotal Phase 3 trial of nomacopan in BP » 10:18
    04/12/21
    04/12
    10:18
    04/12/21
    10:18
    AKTX

    Akari Therapeutics

    $2.41 /

    + (+0.00%)

    Akari Therapeutics…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    AKTX Akari Therapeutics
    $2.41 /

    + (+0.00%)

    AKTX Akari Therapeutics
    $2.41 /

    + (+0.00%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.